2015 prize winners

AstraZeneca Young Investigator Prize
British Association of Cancer Research (BACR)/Gordon Hamilton-Fairley Young Investigator Award
British Association of Cancer Research (BACR) AstraZeneca Young Scientist Frank Rose Award
British Association of Cancer Research (BACR) Translational Award
Cancer Research UK Future Leaders in Cancer Research Prize
Cancer Research UK Translational Cancer Research Prize
Cancer Research UK Lifetime Achievement in Cancer Research Prize
Children’s Cancer and Leukaemia Group (CCLG) McElwain Award
The Company of Biologists Travel Awards
European Association for Cancer Research Travel Awards
National Cancer Research Institute (NCRI) Prize Awards
Royal College of Radiologists Ross Prizes
Teenage Cancer Trust Stephen Sutton Prize

IMG_4016 IMG_4813  IMG_4036 IMG_4027 IMG_4818 IMG_4011 IMG_4827 IMG_4833-2

AstraZeneca Investigator Poster Prize

Exosome switching: an mTORC1-dependent cellular stress response
Deborah Goberdhan, University of Oxford, UK

British Association of Cancer Research (BACR) Gordon Hamilton-Fairley Young Investigator Award

Individual patient oesophageal cancer models for tailored treatment
John H Saunders et al., University of Nottingham & Nottingham University Hospitals, UK

British Association of Cancer Research (BACR) AstraZeneca Young Scientist Frank Rose Award

Polyubiquitylation drives replisome disassembly at the termination of eukaryotic DNA replication
Agnieszka Gambus, University of Birmingham, UK

British Association of Cancer Research (BACR) Translational Award

Implementing personalised medicine in melanoma patients
Maria Romina Girotti, Cancer Research UK Manchester Institute, UK

Cancer Research UK Future Leaders in Cancer Research Prize

Dr Peter Van Loo, The Francis Crick Institute, London, UK
Dr Chris Bakal, The Institute of Cancer Research, London, UK
Dr John Brognard, Cancer Research UK Manchester Institute, UK

Cancer Research UK Translational Cancer Research Prize

EBV Vaccine Team led by Professor Alan Rickinson
Dr Graham Taylor, Dr Neil Steven, Dr Ceri Edwards, Dr Lesley McGuigan
University of Birmingham and Cancer Research UK Centre for Drug Development

Cancer Research UK Lifetime Achievement in Cancer Research Prize

Professor Mel Greaves, The Institute of Cancer Research, London, UK

Children’s Cancer and Leukaemia Group (CCLG) McElwain Award

Adamantinomatous craniopharyngioma contains senescent cells with tumour-inducing potential
Juan Pedro Martinez-Barbera, University College London, UK

The Company of Biologists Travel Awards

The Company of Biologists recognises the importance and interest of the NCRI Cancer Conference for students and young post-docs travelling from countries outside of the EU. Recipients of the awards received a bursary of up to £800.00 to contribute to their travel expenses.

Deaths, DALY and Other related measures are high among Yemeni Breast cancer Women
Amen Bawazir, Ministry of National Guard – Health Affairs, Saudi Arabia

Correlation of clinico-pathological outcomes with changes in IHC4 status after neo-adjuvant chemotherapy (NACT) for locally advanced breast cancers: Do pre NACT ER/PR status act as better prognosticators?
Animesh Saha, Tata Medical Center, Kolkata, India

Salinomycin targets EZH2 driven epigenetic repression of death receptors in colon cancer stem cells
Anup Kumar Singh, CSIR-Central Drug Research Institute, India

DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis
Chin Wen Png, National University of Singapore

A study of the relationship between intratumor morphological heterogeneity and genetic changes in breast cancer
Evgeny Denisov, Tomsk Cancer Research Institute, Russia

DNA excision repair mediates adaptive response to low doses of ionizing radiation in C57BL/6J mice
Youssef Ismail, Canadian Nuclear Laboratories, Canada

European Association for Cancer Research Travel Awards

The EACR recognises the importance and interest of the NCRI Cancer Conference for delegates travelling from EU countries. Recipients of the awards received a bursary of up to €500.00 to contribute to their travel expenses.

Mesenchymal to Amoeboid Invasion Transition in Width- and Height-Confined Channels
Andrew Holle, Max Planck Institute for Intelligent Systems, Germany

A clinical correlation study of ALK-rearranged circulating tumour cell subsets under crizotinib therapy – to assess for their potential role as predictive biomarkers in non-small-cell lung carcinoma
Kirsty Ross, Institut Gustave Roussy, France

New Possible Targetable Genes For Future Treatment of MLL Leukemias
Senol Dogan, International Burch University, Bosnia & Herzegovina

SF3B1 and EIF1AX mutations in Uveal Melanoma
Serdar Yavuzyigitoglu, Rasmus MC, Department of Clinical Genetics and Department of Ophthalmology, Rotterdam, The Netherlands

National Cancer Research Institute (NCRI) Prize Awards

The NCRI Prize Awards give basic and clinical researchers undertaking or within one year of graduation a prize bursary of up to £250 towards the cost of attending the Conference. Applicants for this award were asked why they chose to attend the NCRI Cancer Conference and how their research and career will benefit by attending. The winners of the awards were selected on the basis of both the quality of their abstract and the strength of their supporting application.

Salinomycin targets EZH2 driven epigenetic repression of death receptors in colon cancer stem cells
Anup Kumar Singh et al, CSIR-Central Drug Research Institute, India

Target coverage during image-guided radiotherapy for prostate cancer – how relevant is the initial rectal volume?
Hemal Ariyaratne et al,  Mount Vernon Cancer Centre, London, UK

Hyperglycaemia is associated with intermediate and high grade prostate cancer among Swedish men
Rhonda Arthur et al,  King’s College London, UK

Host-derived MMP-7 inhibits myeloma development via cleavage of galectin-3; an unexpected role for MMP-7 and galectin-3 in myeloma pathogenesis
Seint The Su Lwin et al,  University of Oxford, UK

Role of WSB-1 in the biology of tumour hypoxia in breast cancer
Flore-Anne Poujade et al,  The University of Hull, UK

Optimising Ambulatory Chemotherapy Services: A System for Monitoring Drug Delivery in Elastomeric Pumps
Dahlia Salman et al,  Kingston University, UK

Use of diffusion weighted-MRI (DW-MRI) as a biomarker of clinical outcome in muscle invasive bladder cancer (MIBC)
Shaista Hafeez et al, The Institute of Cancer Research, London, UK

Royal College of Radiologists Ross Prizes

Endowed by Dr WM Ross, a past President of the College, these awards are presented to the clinical oncologists in training or recently appointed consultants adjudged to have presented the best proffered papers, posters or videos at a College meeting. The procedure for determining these awards was originally set by the Board of Faculty of Clinical Oncology.

Two prizes are awarded annually at the NCRI Cancer Conference: One for the best poster and one for the best proffered paper presentation.

Best poster: Characterisation of tumour boost with diffusion weighted MRI (DW-MRI) to inform biological target volume for radical radiotherapy in muscle invasive bladder cancer (MIBC)
Shaista Hafeez, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK

Best proffered paper: Biodistribution and radiation dosimetry of a novel 18F-fluoroethyl triazole [Tyr3] octreotate analogue for PET imaging in patients with advanced neuroendocrine tumours
Suraiya Dubash, Imperial College, London, UK

Teenage Cancer Trust Stephen Sutton Prize

The Teenage Cancer Trust Stephen Sutton Prize is awarded to researchers who are judged to have submitted top quality research in colorectal cancer and/or research in the field of teenagers and young adults. The first and second prize winners receive a bursary for £750 and £250, respectively.

First prize: Natural Killer Cell-like signature observed in locally advanced rectal cancer after neoadjuvant chemoradiotherapy in a tumour regression grade dependent manner
Matthew Alderdice, Centre for Cancer Research and Cell Biology, Queen’s University Belfast, UK

Second prize: Chromosomal catastrophes and punctuated evolution in colorectal carcinogenesis
William Cross, Barts Cancer Institute, London, UK